Altesa BioSciences Reveals Promising Phase 2 Results for Vapendavir in COPD Treatment Altesa BioSciences has released promising results from a Phase 2 study of Vapendavir for treating rhinovirus in COPD patients, showing significant improvements.

Altesa BioSciences Reveals Promising Phase 2 Results for Vapendavir in COPD Treatment #United_States #College_Park #COPD #Vapendavir #Altesa